Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Unge

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Virology|January 10, 1995
Enhancement of HIV-1 proteinase activity by HIV-1 reverse transcriptaseL Goobar-Larsson, B G Luukkonen, T Unge, et al.
The Journal of General Virology|August 1, 1991
Immunological characterization of the human immunodeficiency virus type 1 reverse transcriptase protein by the use of monoclonal antibodiesC Orvell, T Unge, R Bhikhabhai, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1997
Differential gene expression of steroid 5 alpha-reductase 2 in core needle biopsies from malignant and benign prostatic tissueC Bjelfman, T G Söderström, E Brekkan, et al.
Virology|October 1, 1993
Disruption of a salt bridge between Asp 488 and Lys 465 in HIV-1 reverse transcriptase alters its proteolytic processing and polymerase activityL Goobar-Larsson, K Bäckbro, T Unge, et al.
Journal of Virology|March 10, 2001
Human immunodeficiency virus type 1 central DNA flap: dynamic terminal product of plus-strand displacement dna synthesis catalyzed by reverse transcriptase assisted by nucleocapsid proteinL Hameau, J Jeusset, S Lafosse, et al.
AIDS Research and Human Retroviruses|August 25, 2000
Monoclonal antibodies to native HIV type 1 reverse transcriptase and their interaction with enzymes from different subtypesA S Rytting, L Akerblom, J Albert, et al.
Journal of Medicinal Chemistry|March 14, 1997
Unexpected binding mode of a cyclic sulfamide HIV-1 protease inhibitorK Bäckbro, S Löwgren, K Osterlund, et al.
Journal of Medicinal Chemistry|October 9, 1999
Inhibitors of the C(2)-symmetric HIV-1 protease: nonsymmetric binding of a symmetric cyclic sulfamide with ketoxime groups in the P2/P2' side chainsJ Hultén, H O Andersson, W Schaal, et al.
Journal of Medicinal Chemistry|September 7, 2001
Design and synthesis of potent C(2)-symmetric diol-based HIV-1 protease inhibitors: effects of fluoro substitutionD Pyring, J Lindberg, Rosenquist A, et al.
AIDS Research and Human Retroviruses|November 1, 1990
Expression, purification, and crystallization of the HIV-1 reverse transcriptase (RT)T Unge, H Ahola, R Bhikhabhai, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Virology|January 10, 1995
Enhancement of HIV-1 proteinase activity by HIV-1 reverse transcriptaseL Goobar-Larsson, B G Luukkonen, T Unge, et al.
The Journal of General Virology|August 1, 1991
Immunological characterization of the human immunodeficiency virus type 1 reverse transcriptase protein by the use of monoclonal antibodiesC Orvell, T Unge, R Bhikhabhai, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1997
Differential gene expression of steroid 5 alpha-reductase 2 in core needle biopsies from malignant and benign prostatic tissueC Bjelfman, T G Söderström, E Brekkan, et al.
Virology|October 1, 1993
Disruption of a salt bridge between Asp 488 and Lys 465 in HIV-1 reverse transcriptase alters its proteolytic processing and polymerase activityL Goobar-Larsson, K Bäckbro, T Unge, et al.
Journal of Virology|March 10, 2001
Human immunodeficiency virus type 1 central DNA flap: dynamic terminal product of plus-strand displacement dna synthesis catalyzed by reverse transcriptase assisted by nucleocapsid proteinL Hameau, J Jeusset, S Lafosse, et al.
AIDS Research and Human Retroviruses|August 25, 2000
Monoclonal antibodies to native HIV type 1 reverse transcriptase and their interaction with enzymes from different subtypesA S Rytting, L Akerblom, J Albert, et al.
Journal of Medicinal Chemistry|March 14, 1997
Unexpected binding mode of a cyclic sulfamide HIV-1 protease inhibitorK Bäckbro, S Löwgren, K Osterlund, et al.
Journal of Medicinal Chemistry|October 9, 1999
Inhibitors of the C(2)-symmetric HIV-1 protease: nonsymmetric binding of a symmetric cyclic sulfamide with ketoxime groups in the P2/P2' side chainsJ Hultén, H O Andersson, W Schaal, et al.
Journal of Medicinal Chemistry|September 7, 2001
Design and synthesis of potent C(2)-symmetric diol-based HIV-1 protease inhibitors: effects of fluoro substitutionD Pyring, J Lindberg, Rosenquist A, et al.
AIDS Research and Human Retroviruses|November 1, 1990
Expression, purification, and crystallization of the HIV-1 reverse transcriptase (RT)T Unge, H Ahola, R Bhikhabhai, et al.
Pageof 4